Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Jul;64(7):2709–2715. doi: 10.1128/iai.64.7.2709-2715.1996

Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

E Konadu 1, J Shiloach 1, D A Bryla 1, J B Robbins 1, S C Szu 1
PMCID: PMC174130  PMID: 8698499

Abstract

Salmonella paratyphi A, the second most common cause of enteric fever in Southeast Asia, is a habitant of and a pathogen for humans only. Lipopolysaccharides (LPS) are both essential virulence factors and protective antigens for systemic infections caused by groups A, B, C, and D nontyphoidal salmonellae. The O-specific polysaccharide of S. paratyphi A is composed of a trisaccharide, -->2-alpha-D)-Manp-(1-->4)-alpha-L-Rhap-(1-->3)-alpha-D-Galp -(1-->, with a branch of D-paratose from the C-3 of alpha-D-mannose, and the C-3 of beta-L-rhamnose is partially O acetylated (C. G. Hellerqvist, B. Lindberg, K. Samuelsson, and A. A. Lindberg, Acta Chem. Scand. 25:955-961, 1971). On the basis of data from our investigational vaccines for enteric bacterial pathogens, including group B salmonellae (D. C. Watson, J. B. Robbins, and S. C. Szu, Infect. Immun. 60:4679-4686, 1992), conjugates composed of the detoxified LPS of S. paratyphi A bound to tetanus toxoid (TT) were prepared by several schemes. LPS was detoxified with acetic acid or with hydrazine; the latter removed O acetyls from the O-specific polysaccharide. The detoxified polysaccharides were activated with cyanogen bromide (CNBr) or with 1-cyano-4-dimethylaminopyridinium tetratfluoroborate (CDAP) and bound to TT with or without a spacer. Solutions of 2.5 microgram of saccharide, alone or as a conjugate, were injected subcutaneously into young mice, and LPS and TT antibodies were measured by enzyme-linked immunosorbent assaying. A conjugate synthesized with higher-molecular-weight O-SP elicited the highest anti-LPS levels. Only conjugates with O acetyls elicited serum immunoglobulin G anti-LPS with bactericidal activity. There were no statistically significant differences between LPS antibody levels elicited by conjugates synthesized with or without a spacer. The conjugate with O-specific polysaccharide activated by CDAP and bound to TT without a spacer elicited the highest level of TT antibodies. Clinical evaluation (if S. paratyphi A conjugates is planned.

Full Text

The Full Text of this article is available as a PDF (330.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acharya G., Butler T., Ho M., Sharma P. R., Tiwari M., Adhikari R. K., Khagda J. B., Pokhrel B., Pathak U. N. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg. 1995 Feb;52(2):162–165. doi: 10.4269/ajtmh.1995.52.162. [DOI] [PubMed] [Google Scholar]
  2. Acharya I. L., Lowe C. U., Thapa R., Gurubacharya V. L., Shrestha M. B., Cadoz M., Schulz D., Armand J., Bryla D. A., Trollfors B. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med. 1987 Oct 29;317(18):1101–1104. doi: 10.1056/NEJM198710293171801. [DOI] [PubMed] [Google Scholar]
  3. Adeyokunnu A. A., Hendrickse R. G. Salmonella osteomyelitis in childhood. A report of 63 cases seen in Nigerian children of whom 57 had sickle cell anaemia. Arch Dis Child. 1980 Mar;55(3):175–184. doi: 10.1136/adc.55.3.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anand A. C., Kataria V. K., Singh W., Chatterjee S. K. Epidemic multiresistant enteric fever in eastern India. Lancet. 1990 Feb 10;335(8685):352–352. doi: 10.1016/0140-6736(90)90635-i. [DOI] [PubMed] [Google Scholar]
  5. Baumgartner J. D., Heumann D., Calandra T., Glauser M. P. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. J Infect Dis. 1991 Apr;163(4):769–772. doi: 10.1093/infdis/163.4.769. [DOI] [PubMed] [Google Scholar]
  6. Bhutta Z. A., Farooqui B. J., Sturm A. W. Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacin. J Infect. 1992 Sep;25(2):215–219. doi: 10.1016/0163-4453(92)94173-u. [DOI] [PubMed] [Google Scholar]
  7. Bhutta Z. A., Naqvi S. H., Razzaq R. A., Farooqui B. J. Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis. 1991 Sep-Oct;13(5):832–836. doi: 10.1093/clinids/13.5.832. [DOI] [PubMed] [Google Scholar]
  8. Blaser M. J., Feldman R. A. From the centers for disease control. Salmonella bacteremia: reports to the Centers for Disease Control, 1968-1979. J Infect Dis. 1981 May;143(5):743–746. doi: 10.1093/infdis/143.5.743. [DOI] [PubMed] [Google Scholar]
  9. Bock K., Meldal M., Bundle D. R., Iversen T., Garegg P. J., Norberg T., Lindberg A. A., Svenson S. B. The conformation of Salmonella O-antigenic polysaccharide chains of serogroups A, B, and D1 predicted by semi-empirical, Hard-Sphere (HSEA) calculations. Carbohydr Res. 1984 Jul 15;130:23–34. doi: 10.1016/0008-6215(84)85267-2. [DOI] [PubMed] [Google Scholar]
  10. Bock K., Meldal M., Bundle D. R., Iversen T., Pinto B. M., Garegg P. J., Kvanström I., Norberg T., Lindberg A. A., Svenson S. B. The conformation of Salmonella O-antigenic oligosaccharides of serogroups A, B, and D1 inferred from 1H- and 13C-nuclear magnetic resonance spectroscopy. Carbohydr Res. 1984 Jul 15;130:35–53. doi: 10.1016/0008-6215(84)85268-4. [DOI] [PubMed] [Google Scholar]
  11. Carlin N. I., Svenson S. B., Lindberg A. A. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb Pathog. 1987 Mar;2(3):171–183. doi: 10.1016/0882-4010(87)90019-2. [DOI] [PubMed] [Google Scholar]
  12. Celum C. L., Chaisson R. E., Rutherford G. W., Barnhart J. L., Echenberg D. F. Incidence of salmonellosis in patients with AIDS. J Infect Dis. 1987 Dec;156(6):998–1002. doi: 10.1093/infdis/156.6.998. [DOI] [PubMed] [Google Scholar]
  13. Chalker R. B., Blaser M. J. A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis. 1988 Jan-Feb;10(1):111–124. doi: 10.1093/clinids/10.1.111. [DOI] [PubMed] [Google Scholar]
  14. Chu C. Y., Liu B. K., Watson D., Szu S. S., Bryla D., Shiloach J., Schneerson R., Robbins J. B. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun. 1991 Dec;59(12):4450–4458. doi: 10.1128/iai.59.12.4450-4458.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Colwell D. E., Michalek S. M., Briles D. E., Jirillo E., McGhee J. R. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium. J Immunol. 1984 Aug;133(2):950–957. [PubMed] [Google Scholar]
  16. Cygler M., Rose D. R., Bundle D. R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 1991 Jul 26;253(5018):442–445. doi: 10.1126/science.1713710. [DOI] [PubMed] [Google Scholar]
  17. DeMaria A., Jr, Johns M. A., Berberich H., McCabe W. R. Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J Infect Dis. 1988 Aug;158(2):301–311. doi: 10.1093/infdis/158.2.301. [DOI] [PubMed] [Google Scholar]
  18. Ebong W. W. Acute osteomyelitis in Nigerians with sickle cell disease. Ann Rheum Dis. 1986 Nov;45(11):911–915. doi: 10.1136/ard.45.11.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Escamilla J., Florez-Ugarte H., Kilpatrick M. E. Evaluation of blood clot cultures for isolation of Salmonella typhi, Salmonella paratyphi-A, and Brucella melitensis. J Clin Microbiol. 1986 Sep;24(3):388–390. doi: 10.1128/jcm.24.3.388-390.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. FOUQUEY C., POLONSKY J., LEDERER E., WESTPHAL O., LUDERITZ O. Synthesis of 3,6-dideoxy-D-ribo-hexose (3, 6-dideoxy-D-glucose) and its identification with paratose. Nature. 1958 Oct 4;182(4640):944–944. doi: 10.1038/182944a0. [DOI] [PubMed] [Google Scholar]
  21. Frankel G., Newton S. M., Schoolnik G. K., Stocker B. A. Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi. EMBO J. 1989 Oct;8(10):3149–3152. doi: 10.1002/j.1460-2075.1989.tb08468.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. GERICHTER C. B. The dissemination of Salmonella typhi, S. paratyphi A and S. paratyphi B through the organs of the white mouse by oral infection. J Hyg (Lond) 1960 Sep;58:307–319. doi: 10.1017/s0022172400038420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gupta R. K., Szu S. C., Finkelstein R. A., Robbins J. B. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect Immun. 1992 Aug;60(8):3201–3208. doi: 10.1128/iai.60.8.3201-3208.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hafiz S., Khan S. W., Shariff R., Yazdani I., Syed Y., Hafiz T. Epidemiology of salmonellosis and its sensitivity in Karachi. J Pak Med Assoc. 1993 Sep;43(9):178–179. [PubMed] [Google Scholar]
  25. Hargrett-Bean N. T., Pavia A. T., Tauxe R. V. Salmonella isolates from humans in the United States, 1984-1986. MMWR CDC Surveill Summ. 1988 Jun;37(2):25–31. [PubMed] [Google Scholar]
  26. Hellerqvist C. G., Lindberg B., Samuelsson K., Lindberg A. A. Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella parathyphi A var. durazzo. Acta Chem Scand. 1971;25(3):955–961. doi: 10.3891/acta.chem.scand.25-0955. [DOI] [PubMed] [Google Scholar]
  27. Klugman K. P., Gilbertson I. T., Koornhof H. J., Robbins J. B., Schneerson R., Schulz D., Cadoz M., Armand J. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987 Nov 21;2(8569):1165–1169. doi: 10.1016/s0140-6736(87)91316-x. [DOI] [PubMed] [Google Scholar]
  28. Konadu E., Robbins J. B., Shiloach J., Bryla D. A., Szu S. C. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect Immun. 1994 Nov;62(11):5048–5054. doi: 10.1128/iai.62.11.5048-5054.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lasserre R., Sangalang R. P., Santiago L. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. J Antimicrob Chemother. 1991 Nov;28(5):765–772. doi: 10.1093/jac/28.5.765. [DOI] [PubMed] [Google Scholar]
  30. Lee S. C., Yang P. H., Shieh W. B., Lasserre R. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis. 1994 Oct;19(4):693–696. doi: 10.1093/clinids/19.4.693. [DOI] [PubMed] [Google Scholar]
  31. Lepage P., Bogaerts J., Van Goethem C., Ntahorutaba M., Nsengumuremyi F., Hitimana D. G., Vandepitte J., Butzler J. P., Levy J. Community-acquired bacteraemia in African children. Lancet. 1987 Jun 27;1(8548):1458–1461. doi: 10.1016/s0140-6736(87)92207-0. [DOI] [PubMed] [Google Scholar]
  32. Levine W. C., Buehler J. W., Bean N. H., Tauxe R. V. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic. J Infect Dis. 1991 Jul;164(1):81–87. doi: 10.1093/infdis/164.1.81. [DOI] [PubMed] [Google Scholar]
  33. Mahanta J. Drug sensitivity of Salmonella paratyphi A isolated from a suspected outbreak of enteric fever in Duliajan. J Indian Med Assoc. 1994 Feb;92(2):49–50. [PubMed] [Google Scholar]
  34. Nesbitt A., Mirza N. B. Salmonella septicaemias in Kenyan children. J Trop Pediatr. 1989 Feb;35(1):35–39. doi: 10.1093/tropej/35.1.35. [DOI] [PubMed] [Google Scholar]
  35. Nguyen T. A., Ha Ba K., Nguyen T. D. La fièvre typhoïde au sud du Viet-Nam, 1990-1993. Bull Soc Pathol Exot. 1993;86(5 Pt 2):476–478. [PubMed] [Google Scholar]
  36. Nourmand A., Ziai M., Tahernia A. C. Typhoid-paratyphoid fevers in infancy. Experiences with 35 cases. Clin Pediatr (Phila) 1971 May;10(5):272–274. doi: 10.1177/000992287101000510. [DOI] [PubMed] [Google Scholar]
  37. Orskov F., Orskov I. From the national institutes of health. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the enterobacteriaceae and other bacteria. J Infect Dis. 1983 Aug;148(2):346–357. doi: 10.1093/infdis/148.2.346. [DOI] [PubMed] [Google Scholar]
  38. Orskov F., Orskov I., Sutton A., Schneerson R., Lin W., Egan W., Hoff G. E., Robbins J. B. Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med. 1979 Mar 1;149(3):669–685. doi: 10.1084/jem.149.3.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Peeters C. C., Tenbergen-Meekes A. M., Evenberg D. E., Poolman J. T., Zegers B. J., Rijkers G. T. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J Immunol. 1991 Jun 15;146(12):4308–4314. [PubMed] [Google Scholar]
  40. Phillips I., Wharton B. Acute bacterial infection in kwashiorkor and marasmus. Br Med J. 1968 Feb 17;1(5589):407–409. doi: 10.1136/bmj.1.5589.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rao P. S., Bairy I., Rao P. V., Shivananda P. G. Multiresistant Salmonella paratyphi 'A' infection in coastal Karnataka. J Assoc Physicians India. 1994 Nov;42(11):929–929. [PubMed] [Google Scholar]
  42. Reeves M. W., Evins G. M., Heiba A. A., Plikaytis B. D., Farmer J. J., 3rd Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov. J Clin Microbiol. 1989 Feb;27(2):313–320. doi: 10.1128/jcm.27.2.313-320.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Robbins J. B., Chu C., Schneerson R. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin Infect Dis. 1992 Aug;15(2):346–361. doi: 10.1093/clinids/15.2.346. [DOI] [PubMed] [Google Scholar]
  44. Robbins J. B., Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis. 1990 May;161(5):821–832. doi: 10.1093/infdis/161.5.821. [DOI] [PubMed] [Google Scholar]
  45. Robbins J. B., Schneerson R., Szu S. C. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis. 1995 Jun;171(6):1387–1398. doi: 10.1093/infdis/171.6.1387. [DOI] [PubMed] [Google Scholar]
  46. Schwartz E., Shlim D. R., Eaton M., Jenks N., Houston R. The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med. 1990 Feb;150(2):349–351. [PubMed] [Google Scholar]
  47. Schwartzer T. A., Alcid D. V., Numsuwan V., Gocke D. J. Characterization of the human antibody response to an Escherichia coli O111:B4 (J5) vaccine. J Infect Dis. 1988 Nov;158(5):1135–1136. doi: 10.1093/infdis/158.5.1135. [DOI] [PubMed] [Google Scholar]
  48. Simanjuntak C. H., Paleologo F. P., Punjabi N. H., Darmowigoto R., Soeprawoto, Totosudirjo H., Haryanto P., Suprijanto E., Witham N. D., Hoffman S. L. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet. 1991 Oct 26;338(8774):1055–1059. doi: 10.1016/0140-6736(91)91910-m. [DOI] [PubMed] [Google Scholar]
  49. Svenson S. B., Lindberg A. A. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun. 1981 May;32(2):490–496. doi: 10.1128/iai.32.2.490-496.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Szu S. C., Li X. R., Schneerson R., Vickers J. H., Bryla D., Robbins J. B. Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi. Infect Immun. 1989 Dec;57(12):3823–3827. doi: 10.1128/iai.57.12.3823-3827.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Szu S. C., Li X. R., Stone A. L., Robbins J. B. Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect Immun. 1991 Dec;59(12):4555–4561. doi: 10.1128/iai.59.12.4555-4561.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Taylor D. N., Trofa A. C., Sadoff J., Chu C., Bryla D., Shiloach J., Cohen D., Ashkenazi S., Lerman Y., Egan W. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun. 1993 Sep;61(9):3678–3687. doi: 10.1128/iai.61.9.3678-3687.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Thisyakorn U., Mansuwan P., Taylor D. N. Typhoid and paratyphoid fever in 192 hospitalized children in Thailand. Am J Dis Child. 1987 Aug;141(8):862–865. doi: 10.1001/archpedi.1987.04460080048025. [DOI] [PubMed] [Google Scholar]
  54. Tran T. H., Bethell D. B., Nguyen T. T., Wain J., To S. D., Le T. P., Bui M. C., Nguyen M. D., Pham T. T., Walsh A. L. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis. 1995 Apr;20(4):917–923. [PubMed] [Google Scholar]
  55. Tsai C. M. The analysis of lipopolysaccharide (endotoxin) in meningococcal polysaccharide vaccines by silver staining following SDS-polyacrylamide gel electrophoresis. J Biol Stand. 1986 Jan;14(1):25–33. doi: 10.1016/s0092-1157(86)80006-3. [DOI] [PubMed] [Google Scholar]
  56. Verghese S. L., Manonmani R., Balasubramanian S., Chandrasekharan S. Multi-drug resistance in salmonellae isolated from enteric fever cases at Porur--a semi urban area near Madras City. J Commun Dis. 1992 Mar;24(1):12–15. [PubMed] [Google Scholar]
  57. Watson D. C., Robbins J. B., Szu S. C. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect Immun. 1992 Nov;60(11):4679–4686. doi: 10.1128/iai.60.11.4679-4686.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Webb D. K., Serjeant G. R. Systemic Salmonella infections in sickle cell anaemia. Ann Trop Paediatr. 1989 Sep;9(3):169–172. doi: 10.1080/02724936.1989.11748623. [DOI] [PubMed] [Google Scholar]
  59. ZIMMERMAN L. E., COOPER M., GRABER C. D. Bacteriologic studies in an outbreak of salmonellosis in Korea, with special attention to Salmonella paratyphi and perforations of paratyphoid ulcers. Am J Hyg. 1952 Nov;56(3):252–264. doi: 10.1093/oxfordjournals.aje.a119550. [DOI] [PubMed] [Google Scholar]
  60. Zarkowsky H. S., Gallagher D., Gill F. M., Wang W. C., Falletta J. M., Lande W. M., Levy P. S., Verter J. I., Wethers D. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986 Oct;109(4):579–585. doi: 10.1016/s0022-3476(86)80216-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES